Close
RNS Number : 5610L
Hikma Pharmaceuticals Plc
06 September 2019
 

Notification and public disclosure of transactions by person discharging managerial responsibilities

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Disposal of 150,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by Banque Lombard Odier & Cie SA

c)

Price(s) and volume(s)

Price(s): £20.56

Volume(s): 49,826

Price(s): £19.85

Volume(s): 25,000

Price(s): £19.82

Volume(s): 25,000

Price(s): £19.84

Volume(s): 25,000

Price(s): £19.82

Volume(s): 25,174

d)

Aggregated information

Aggregated volume: 150,000

Price: £20.07

Total: £3,011,121

e)

Date of the transaction

4 and 6 September 2019

f)

Place of the transaction

London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

6 September 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBSGDCXDGBGCL